HBK Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$206K	–	129
2024 Q2	$206K	Buy	+5,000	New	+$206K	﹤0.01%	95
2015 Q4	–	Sell	-42,737	Closed	-$4.12M	–	1010
2015 Q3	$4.12M	Buy	+42,737	New	+$4.12M	0.04%	211